Indication
Invasive Candidiasis
4 clinical trials
9 products
Product
IbrexafungerpClinical trial
Open-Label Study to Evaluate the Efficacy and Safety of SCY-078 (Ibrexafungerp) in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment (FURI)Status: Completed, Estimated PCD: 2023-08-17
Clinical trial
An Open Clinical Trial to Evaluate the Safety, Efficacy and Population Pharmacokinetics of Amphotericin B Cholesteryl Sulfate Complex for Injection in Subjects With Invasive Candidiasis and Invasive AspergillusStatus: Not yet recruiting, Estimated PCD: 2025-08-15
Clinical trial
A Phase 3, Multicenter, Randomized, Double-Blind Study of the Efficacy and Safety of Rezafungin for Injection Versus the Standard Antimicrobial Regimen to Prevent Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation (The ReSPECT Study)Status: Recruiting, Estimated PCD: 2024-08-01
Product
RezafunginProduct
PosaconazoleProduct
FluconazoleProduct
Intravenous PlaceboProduct
Oral PlaceboClinical trial
Diagnostic Value of PCR Genetic Amplification and Mannan Antigenemia Coupled With Antimannan Antibodies in Intensive Care Patients With Suspected Invasive CandidiasisStatus: Completed, Estimated PCD: 2019-09-17
Product
Blood sample